Tower Research Capital (TRC)’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$91.5K Sell
1,199
-3,844
-76% -$277K ﹤0.01% 2258
2025
Q4
$322K Buy
5,043
+2,442
+94% +$151K 0.01% 1106
2025
Q3
$164K Sell
2,601
-18,106
-87% -$1.26M ﹤0.01% 1629
2025
Q2
$1.55M Buy
20,707
+12,814
+162% +$1.01M 0.04% 378
2025
Q1
$695K Buy
7,893
+2,077
+36% +$196K 0.02% 671
2024
Q4
$531K Buy
5,816
+2,637
+83% +$270K 0.01% 1016
2024
Q3
$356K Sell
3,179
-2,815
-47% -$282K 0.01% 1108
2024
Q2
$587K Buy
5,994
+1,328
+28% +$132K 0.01% 1205
2024
Q1
$468K Sell
4,666
-10,573
-69% -$930K 0.01% 906
2023
Q4
$1.37M Buy
15,239
+9,072
+147% +$723K 0.02% 666
2023
Q3
$473K Sell
6,167
-11,571
-65% -$960K 0.01% 898
2023
Q2
$1.49M Buy
17,738
+13,518
+320% +$1.1M 0.05% 319
2023
Q1
$356K Buy
4,220
+1,006
+31% +$86.4K 0.01% 1033
2022
Q4
$262K Sell
3,214
-15,813
-83% -$1.27M 0.01% 1117
2022
Q3
$1.35M Buy
19,027
+6,837
+56% +$614K 0.02% 573
2022
Q2
$1.09M Sell
12,190
-16,201
-57% -$1.68M 0.02% 637
2022
Q1
$3.18M Buy
28,391
+17,772
+167% +$2.08M 0.03% 443
2021
Q4
$1.28M Buy
10,619
+2,128
+25% +$237K 0.02% 565
2021
Q3
$856K Sell
8,491
-1,839
-18% -$203K 0.02% 632
2021
Q2
$1.21M Sell
10,330
-19,955
-66% -$2.4M 0.03% 535
2021
Q1
$3.33M Buy
30,285
+13,188
+77% +$1.43M 0.06% 313
2020
Q4
$1.72M Buy
17,097
+9,104
+114% +$844K 0.05% 265
2020
Q3
$625K Buy
7,993
+3,723
+87% +$281K 0.01% 1438
2020
Q2
$297K Buy
+4,270
New +$269K 0.01% 1448
2020
Q1
Sell
-414
Closed -$33K 3246
2019
Q4
$33K Sell
414
-5,732
-93% -$441K ﹤0.01% 1597
2019
Q3
$454K Buy
6,146
+5,806
+1,708% +$417K 0.03% 605
2019
Q2
$27K Sell
340
-7,924
-96% -$602K ﹤0.01% 1964
2019
Q1
$627K Buy
8,264
+2,255
+38% +$179K 0.04% 475
2018
Q4
$439K Buy
6,009
+3,840
+177% +$306K 0.03% 457
2018
Q3
$208K Sell
2,169
-19,577
-90% -$1.94M 0.02% 950
2018
Q2
$2.17M Buy
+21,746
New +$2.3M 0.12% 152
2018
Q1
Sell
-1,521
Closed -$141K 3387
2017
Q4
$141K Buy
1,521
+1,293
+567% +$117K 0.02% 714
2017
Q3
$21K Sell
228
-49
-18% -$4.17K ﹤0.01% 2697
2017
Q2
$23K Buy
277
+168
+154% +$13.5K ﹤0.01% 1137
2017
Q1
$9K Sell
109
-2,271
-95% -$179K ﹤0.01% 1841
2016
Q4
$179K Buy
2,380
+1,825
+329% +$132K 0.02% 674
2016
Q3
$38K Buy
555
+75
+16% +$5.03K ﹤0.01% 1281
2016
Q2
$33K Sell
480
-4,936
-91% -$363K ﹤0.01% 1850
2016
Q1
$391K Buy
5,416
+5,098
+1,603% +$334K 0.06% 212
2015
Q4
$21K Buy
+318
New +$22.2K ﹤0.01% 1240
2015
Q3
Sell
-1,893
Closed -$155K 4182
2015
Q2
$155K Buy
+1,893
New +$146K 0.01% 506
2015
Q1
Sell
-1,600
Closed -$121K 4512
2014
Q4
$121K Buy
1,600
+848
+113% +$67K 0.01% 509
2014
Q3
$61K Buy
752
+627
+502% +$52.3K 0.01% 1361
2014
Q2
$11K Sell
125
-346
-73% -$30.1K ﹤0.01% 2274
2014
Q1
$41K Sell
471
-1,015
-68% -$83.2K 0.01% 1238
2013
Q4
$120K Sell
1,486
-6,616
-82% -$514K 0.02% 758
2013
Q3
$631K Buy
8,102
+7,582
+1,458% +$584K 0.07% 263
2013
Q2
$36K Buy
+520
New +$36.2K ﹤0.01% 1184

Other funds holding EMN

Tower Research Capital (TRC)'s EMN Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Eastman Chemical (EMN) stake by 76% in Q1 2026, selling an estimated $277K and leaving 1,199 shares worth $91.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2258.

Tower Research Capital (TRC) first reported a position in EMN in Q2 2013 and has held it in 48 quarters since. The position peaked at $3.33M in Q1 2021. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Tower Research Capital (TRC) held 1,199 shares of Eastman Chemical worth $91.5K as of Q1 2026.
  • Tower Research Capital (TRC) sold 3,844 Eastman Chemical shares in Q1 2026, an estimated $277K.
  • Eastman Chemical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2258 holding.
  • Tower Research Capital (TRC) first reported a position in Eastman Chemical in Q2 2013 and has held it in 48 quarters since.
  • Tower Research Capital (TRC)'s Eastman Chemical position peaked at $3.33M in Q1 2021.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.